Volume 16 Issue 9 - 2021
Fish Oil? Is it Upgrade to Snake Oil?
Paul Clayton*
Clinical Pharmacologist and Pharmaco-Nutritionist, United Kingdom
*Corresponding Author: Paul Clayton, Clinical Pharmacologist and Pharmaco-Nutritionist, United Kingdom.
Received: August 07, 2021; Published: August 28, 2021

Fish oil companies don’t sell snake oil. Perhaps they should… 

I have spoken to the management of some of the biggest fish oil companies and they acknowledge (off the record) that their products don’t do much. But hey – it’s great business. No matter that they are emptying the oceans, making false claims, and taking money from customers who get little more for their hard-earned cash than indigestion and a false sense of security.


  1. Alex A., et al. “Long-chain omega-3 polyunsaturated fatty acids and cognitive decline in non-demented adults: a systematic review and meta-analysis”. Nutrition Reviews7 (2020): 563-578.
  2. Chen X., et al. “Efficacy of fish oil and its components in the management of psoriasis: a systematic review of 18 randomized controlled trials”. Nutrition Reviews10 (2020): 827-840.
  3. Schwartz SG., et al. “Vitamin A and fish oils for preventing the progression of retinitis pigmentosa”. The Cochrane Database of Systematic Reviews6 (2020): CD008428.
  4. Griffith RJ., et al. “Interventions to prevent women from developing gestational diabetes mellitus: an overview of Cochrane Reviews”. The Cochrane Database of Systematic Reviews6 (2020): CD012394.
  5. Gao C., et al. “Effects of fish oil supplementation on glucose control and lipid levels among patients with type 2 diabetes mellitus: a Meta-analysis of randomized controlled trials”. Lipids in Health and Disease1 (2020): 87.
  6. Watson H and Stackhouse C. “Omega-3 fatty acid supplementation for cystic fibrosis”. The Cochrane Database of Systematic Reviews4 (2020): CD002201.
  7. Abdelhamid AS., et al. “Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease”. The Cochrane Database of Systematic Reviews2 (2020): CD003177.
  8. Chewcharat A., et al. “The effects of omega-3 fatty acids on diabetic nephropathy: A meta-analysis of randomized controlled trials”. PLoS One2 (2020): e0228315.
  9. Alvarez Campano CG., et al. “Marine-derived n-3 fatty acids therapy for stroke”. The Cochrane Database of Systematic Reviews6 (2019): CD012815.
  10. Popoff F., et al. “Omega 3 fatty acid supplementation after myocardial infarction: a systematic review and meta-analysis”. BMC Cardiovascular Disorders1 (2019): 136.
  11. Saglimbene VM., et al. “Effects of omega-3 polyunsaturated fatty acid intake in patients with chronic kidney disease: Systematic review and meta-analysis of randomized controlled trials”. Clinical Nutrition2 (2020): 358-368.
  12. Abdullah M., et al. “The effectiveness of omega-3 supplementation in reducing ADHD associated symptoms in children as measured by the Conners’ rating scales: A systematic review of randomized controlled trials”. Journal of Psychiatric Research 110 (2019): 64-73.
  13. Mohammady M., et al. “Effect of omega-3 supplements on vasomotor symptoms in menopausal women: A systematic review and meta-analysis”. European Journal of Obstetrics and Gynecology and Reproductive Biology 228 (2018): 295-302.
  14. Ajabnoor SM., et al. “Long-term effects of increasing omega-3, omega-6 and total polyunsaturated fats on inflammatory bowel disease and markers of inflammation: a systematic review and meta-analysis of randomized controlled trials”. European Journal of Nutrition (2020).
  15. Sun L., et al. “Association between omega-3 fatty acid supplementation and lower risk of preterm delivery: a systematic review and meta-analysis”. The Journal of Maternal-Fetal and Neonatal Medicine 17 (2020): 1-10.
  16. Kilchoer B., et al. “Efficacy of Dietary Supplements to Reduce Liver Fat”. Nutrients8 (2020): 2302.
  17. Parks NE., et al. “Dietary interventions for multiple sclerosis-related outcomes”. The Cochrane Database of Systematic Reviews 5 (2020): CD004192.
  18. Brainard JS., et al. “Omega-3, Omega-6, and Polyunsaturated Fat for Cognition: Systematic Review and Meta-analysis of Randomized Trials”. Journal of the American Medical Directors Association 10 (2020): 1439-1450.e21.
  19. Zhang Y., et al. “Effect of omega-3 fatty acids supplementation during childhood in preventing allergic disease: a systematic review and Meta-Analysis”. Journal of Asthma 10 (2020): 1-14.
  20. Yang SJ and Chi CC. “Effects of fish oil supplement on psoriasis: a meta-analysis of randomized controlled trials”. BMC Complementary Medicine and Therapies 1 (2019): 354.
  21. Chewcharat A., et al. “The effects of omega-3 fatty acids on diabetic nephropathy: A meta-analysis of randomized controlled trials”. PLoS One 2 (2020): e0228315.
  22. Huang YH., et al. “Effects of Omega-3 Fatty Acids on Muscle Mass, Muscle Strength and Muscle Performance among the Elderly: A Meta-Analysis”. Nutrients12 (2020): E3739.
  23. Abdelhamid A., et al. “The Relationship Between Omega-3, Omega-6 and Total Polyunsaturated Fat and Musculoskeletal Health and Functional Status in Adults: A Systematic Review and Meta-analysis of RCTs”. Calcified Tissue International4 (2019): 353-372.
  24. Lee KH., et al. “Consumption of Fish and ω-3 Fatty Acids and Cancer Risk: An Umbrella Review of Meta-Analyses of Observational Studies”. Advances in Nutrition5 (2020): 1134-1149.
  25. Yan JH., et al. “Omega-3 polyunsaturated fatty acid supplementation and non-alcoholic fatty liver disease: A meta-analysis of randomized controlled trials”. Medicine37 (2018): e12271.
  26. Bakouei F., et al. “Efficacy of n-3 fatty acids supplementation on the prevention of pregnancy induced-hypertension or preeclampsia: A systematic review and meta-analysis”. Taiwanese Journal of Obstetrics and Gynecology1 (2020): 8-15.
  27. AlAmmar WA., et al. “Effect of omega-3 fatty acids and fish oil supplementation on multiple sclerosis: a systematic review”. Nutritional Neuroscience 28 (2019): 1-11.
  28. Su KP., et al. “Association of Use of Omega-3 Polyunsaturated Fatty Acids With Changes in Severity of Anxiety Symptoms: A Systematic Review and Meta-analysis”. JAMA Network Open5 (2018): e182327.
  29. Jiang L., et al. “Omega-3 fatty acids plus vitamin for women with gestational diabetes or prediabetes: a meta-analysis of randomized controlled studies”. The Journal of Maternal-Fetal and Neonatal Medicine 23 (2020): 1-8.
  30. Morvaridzadeh M., et al. “The effects of omega-3 fatty acid supplementation on inflammatory factors in HIV-infected patients: A systematic review and meta-analysis of randomized clinical trials”. Cytokine 136 (2020): 155298.
  31. Newberry SJ., et al. “Omega-3 Fatty Acids and Maternal and Child Health: An Updated Systematic Review”. Evidence Report/Technology Assessment 224 (2016): 1-826.
  32. Bernasconi AA., et al. “Effect of Omega-3 Dosage on Cardiovascular Outcomes: An Updated Meta-Analysis and Meta-Regression of Interventional Trials”. Mayo Clinic Proceedings (2020).
  33. Sekikawa A., et al. “Effect of High-Dose Marine Omega-3 Fatty Acids on Atherosclerosis: A Systematic Review and Meta-Analysis of Randomized Clinical Trials”. Nutrients 11 (2019): 2599.
  34. Li ZH., et al. “Associations of habitual fish oil supplementation with cardiovascular outcomes and all-cause mortality: evidence from a large population-based cohort study”. British Medical Journal 368 (2020): m456.
  35. Nicholls SJ., et al. “Effect of High-Dose Omega-3 Fatty Acids vs Corn Oil on Major Adverse Cardiovascular Events in Patients at High Cardiovascular Risk: The STRENGTH Randomized Clinical Trial”. JAMA: The Journal of the American Medical Association 22 (2020): 2268-2280.
  36. Manson JE., et al. “VITAL Research Group. Marine n-3 Fatty Acids and Prevention of Cardiovascular Disease and Cancer”. The New England Journal of Medicine 1 (2019): 23-32.
  37. Kalstad AA., et al. “Effects of n-3 Fatty Acid Supplements in Elderly Patients after Myocardial Infarction: A Randomized Controlled Trial”. Circulation (2020).
  38. Zhu Y., et al. “Dietary total fat, fatty acids intake, and risk of cardiovascular disease: a dose-response meta-analysis of cohort studies”. Lipids in Health and Disease1 (2019): 91.
  39. https://vitas.no/
  40. In house data. “Vitas Analytical Services and Zinzino.
  41. AS Clayton PR and Ladi S. “From alga to omega; have we reached peak (fish) oil?” Journal of the Royal Society of Medicine9 (2015): 351-357.
  42. Dutot M., et al. “Antioxidant, anti-inflammatory, and anti-senescence activities of a phlorotannin-rich natural extract from brown seaweed Ascophyllum nodosum”. Biotechnology and Applied Biochemistry 167 (2012): 2234-2240.
  43. Jung HA., et al. “Anti-inflammatory activity of edible brown alga Eisenia bicyclis and its constituents fucosterol and phlorotannins in LPS-stimulated RAW264.7 macrophages”. Food and Chemical Toxicology 59 (2013): 199-206.
  44. Yang YI., et al. “6,6′-Bieckol, isolated from marine alga Ecklonia cava, suppressed LPS-induced nitric oxide and PGE2 production and inflammatory cytokine expression in macrophages: the inhibition of NFκB”. International Immunopharmacology 12 (2012): 510-517.
  45. Wijesinghe WA and Jeon YJ. “Exploiting biological activities of brown seaweed Ecklonia cava for potential industrial applications: a review”. International Journal of Food Sciences and Nutrition 63 (2012): 225-235.
  46. Thomas NV and Kim SK. “Potential pharmacological applications of polyphenolic derivatives from marine brown algae”. Environmental Toxicology and Pharmacology 32 (2011): 325-335.
  47. Wijesekara I., et al. “Phlorotannins from Ecklonia cava (Phaeophyceae): biological activities and potential health benefits”. Biofactors 36 (2010): 408-414.
  48. Vo TS., et al. “Potential targets for anti-inflammatory and anti-allergic activities of marine algae: an overview”. Inflammation and Allergy - Drug Targets 11 (2012): 90-101.
  49. Kim MM., et al. “Phlorotannins in Ecklonia cava extract inhibit matrix metalloproteinase activity”. Life Sciences 79 (2006): 1436-1443.
  50. Kim SK., et al. “Effects of Ecklonia cava ethanolic extracts on airway hyperresponsiveness and inflammation in a murine asthma model: role of suppressor of cytokine signaling”. Biomedicine and Pharmacotherapy 62 (2008): 289-296.
Citation: Paul Clayton. “Fish Oil? Is it Upgrade to Snake Oil?”. EC Nutrition 16.9 (2021): 01-06.

PubMed Indexed Article

EC Pharmacology and Toxicology
LC-UV-MS and MS/MS Characterize Glutathione Reactivity with Different Isomers (2,2' and 2,4' vs. 4,4') of Methylene Diphenyl-Diisocyanate.

PMID: 31143884 [PubMed]

PMCID: PMC6536005

EC Pharmacology and Toxicology
Alzheimer's Pathogenesis, Metal-Mediated Redox Stress, and Potential Nanotheranostics.

PMID: 31565701 [PubMed]

PMCID: PMC6764777

EC Neurology
Differences in Rate of Cognitive Decline and Caregiver Burden between Alzheimer's Disease and Vascular Dementia: a Retrospective Study.

PMID: 27747317 [PubMed]

PMCID: PMC5065347

EC Pharmacology and Toxicology
Will Blockchain Technology Transform Healthcare and Biomedical Sciences?

PMID: 31460519 [PubMed]

PMCID: PMC6711478

EC Pharmacology and Toxicology
Is it a Prime Time for AI-powered Virtual Drug Screening?

PMID: 30215059 [PubMed]

PMCID: PMC6133253

EC Psychology and Psychiatry
Analysis of Evidence for the Combination of Pro-dopamine Regulator (KB220PAM) and Naltrexone to Prevent Opioid Use Disorder Relapse.

PMID: 30417173 [PubMed]

PMCID: PMC6226033

EC Anaesthesia
Arrest Under Anesthesia - What was the Culprit? A Case Report.

PMID: 30264037 [PubMed]

PMCID: PMC6155992

EC Orthopaedics
Distraction Implantation. A New Technique in Total Joint Arthroplasty and Direct Skeletal Attachment.

PMID: 30198026 [PubMed]

PMCID: PMC6124505

EC Pulmonology and Respiratory Medicine
Prevalence and factors associated with self-reported chronic obstructive pulmonary disease among adults aged 40-79: the National Health and Nutrition Examination Survey (NHANES) 2007-2012.

PMID: 30294723 [PubMed]

PMCID: PMC6169793

EC Dental Science
Important Dental Fiber-Reinforced Composite Molding Compound Breakthroughs

PMID: 29285526 [PubMed]

PMCID: PMC5743211

EC Microbiology
Prevalence of Intestinal Parasites Among HIV Infected and HIV Uninfected Patients Treated at the 1o De Maio Health Centre in Maputo, Mozambique

PMID: 29911204 [PubMed]

PMCID: PMC5999047

EC Microbiology
Macrophages and the Viral Dissemination Super Highway

PMID: 26949751 [PubMed]

PMCID: PMC4774560

EC Microbiology
The Microbiome, Antibiotics, and Health of the Pediatric Population.

PMID: 27390782 [PubMed]

PMCID: PMC4933318

EC Microbiology
Reactive Oxygen Species in HIV Infection

PMID: 28580453 [PubMed]

PMCID: PMC5450819

EC Microbiology
A Review of the CD4 T Cell Contribution to Lung Infection, Inflammation and Repair with a Focus on Wheeze and Asthma in the Pediatric Population

PMID: 26280024 [PubMed]

PMCID: PMC4533840

EC Neurology
Identifying Key Symptoms Differentiating Myalgic Encephalomyelitis and Chronic Fatigue Syndrome from Multiple Sclerosis

PMID: 28066845 [PubMed]

PMCID: PMC5214344

EC Pharmacology and Toxicology
Paradigm Shift is the Normal State of Pharmacology

PMID: 28936490 [PubMed]

PMCID: PMC5604476

EC Neurology
Examining those Meeting IOM Criteria Versus IOM Plus Fibromyalgia

PMID: 28713879 [PubMed]

PMCID: PMC5510658

EC Neurology
Unilateral Frontosphenoid Craniosynostosis: Case Report and a Review of the Literature

PMID: 28133641 [PubMed]

PMCID: PMC5267489

EC Ophthalmology
OCT-Angiography for Non-Invasive Monitoring of Neuronal and Vascular Structure in Mouse Retina: Implication for Characterization of Retinal Neurovascular Coupling

PMID: 29333536 [PubMed]

PMCID: PMC5766278

EC Neurology
Longer Duration of Downslope Treadmill Walking Induces Depression of H-Reflexes Measured during Standing and Walking.

PMID: 31032493 [PubMed]

PMCID: PMC6483108

EC Microbiology
Onchocerciasis in Mozambique: An Unknown Condition for Health Professionals.

PMID: 30957099 [PubMed]

PMCID: PMC6448571

EC Nutrition
Food Insecurity among Households with and without Podoconiosis in East and West Gojjam, Ethiopia.

PMID: 30101228 [PubMed]

PMCID: PMC6086333

EC Ophthalmology
REVIEW. +2 to +3 D. Reading Glasses to Prevent Myopia.

PMID: 31080964 [PubMed]

PMCID: PMC6508883

EC Gynaecology
Biomechanical Mapping of the Female Pelvic Floor: Uterine Prolapse Versus Normal Conditions.

PMID: 31093608 [PubMed]

PMCID: PMC6513001

EC Dental Science
Fiber-Reinforced Composites: A Breakthrough in Practical Clinical Applications with Advanced Wear Resistance for Dental Materials.

PMID: 31552397 [PubMed]

PMCID: PMC6758937

EC Microbiology
Neurocysticercosis in Child Bearing Women: An Overlooked Condition in Mozambique and a Potentially Missed Diagnosis in Women Presenting with Eclampsia.

PMID: 31681909 [PubMed]

PMCID: PMC6824723

EC Microbiology
Molecular Detection of Leptospira spp. in Rodents Trapped in the Mozambique Island City, Nampula Province, Mozambique.

PMID: 31681910 [PubMed]

PMCID: PMC6824726

EC Neurology
Endoplasmic Reticulum-Mitochondrial Cross-Talk in Neurodegenerative and Eye Diseases.

PMID: 31528859 [PubMed]

PMCID: PMC6746603

EC Psychology and Psychiatry
Can Chronic Consumption of Caffeine by Increasing D2/D3 Receptors Offer Benefit to Carriers of the DRD2 A1 Allele in Cocaine Abuse?

PMID: 31276119 [PubMed]

PMCID: PMC6604646

EC Anaesthesia
Real Time Locating Systems and sustainability of Perioperative Efficiency of Anesthesiologists.

PMID: 31406965 [PubMed]

PMCID: PMC6690616

EC Pharmacology and Toxicology
A Pilot STEM Curriculum Designed to Teach High School Students Concepts in Biochemical Engineering and Pharmacology.

PMID: 31517314 [PubMed]

PMCID: PMC6741290

EC Pharmacology and Toxicology
Toxic Mechanisms Underlying Motor Activity Changes Induced by a Mixture of Lead, Arsenic and Manganese.

PMID: 31633124 [PubMed]

PMCID: PMC6800226

EC Neurology
Research Volunteers' Attitudes Toward Chronic Fatigue Syndrome and Myalgic Encephalomyelitis.

PMID: 29662969 [PubMed]

PMCID: PMC5898812

EC Pharmacology and Toxicology
Hyperbaric Oxygen Therapy for Alzheimer's Disease.

PMID: 30215058 [PubMed]

PMCID: PMC6133268

News and Events

November Issue Release

We always feel pleasure to share our updates with you all. Here, notifying you that we have successfully released the November issue of respective journals and the latest articles can be viewed on the current issue pages.

Submission Deadline for Upcoming Issue

ECronicon delightfully welcomes all the authors around the globe for effective collaboration with an article submission for the upcoming issue of respective journals. Submissions are accepted on/before December 15, 2022.

Certificate of Publication

ECronicon honors with a "Publication Certificate" to the corresponding author by including the names of co-authors as a token of appreciation for publishing the work with our respective journals.

Best Article of the Issue

Editors of respective journals will always be very much interested in electing one Best Article after each issue release. The authors of the selected article will be honored with a "Best Article of the Issue" certificate.

Certifying for Review

ECronicon certifies the Editors for their first review done towards the assigned article of the respective journals.

Latest Articles

The latest articles will be updated immediately on the articles in press page of the respective journals.